Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Identify bond funds that offer tax-exempt income in retirement and how to incorporate them for tax-efficient withdrawals.
23,934 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Broadcom and Marvell delivered AI-fueled earnings, but the race to sustain AI momentum hinges on scale, software, and...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
A pivotal move in AI investing just happened: a memory-focused chip stock joined Nasdaq, giving investors a new way t...
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
Two leading space-focused stocks pull investors in different directions. Learn how the spacemobile rocket lab: number...
A trio of tech giants is sending a quiet, powerful message about AI infrastructure spending. SpaceX, Alphabet, and SK...
Jennifer Garner faced a pivotal choice: take a four-month filming commitment or stay close to home for her kids. This...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
A potential 50% tariff on Canadian goods could lift construction costs and tighten loan terms. If negotiations fail, ...
Conagra (CAG) faces a pivotal year as 2026 earnings hinge on pricing, cost control, and portfolio focus. This analysi...